| Safety and efficacy of deferasirox in multitransfused Indian children with β-thalassaemia major. | |
| | |
MedLine Citation:
|
PMID: 21262109 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
AIM: To report experience with deferasirox in north Indian children with β-thalassaemia major. METHODS: This prospective study included 40 patients with transfusion-dependent β-thalassaemia major. The patients were receiving deferiprone alone (37 patients) or deferiprone and desferrioxamine combination (three patients) before commencing deferasirox. Patients were clinically monitored every month. Information on side-effects including gastro-intestinal symptoms, skin rash or discoloration, jaundice and complaints regarding vision and hearing were obtained from patient records. Laboratory investigations included complete blood count and renal and liver function tests estimated at baseline and then every month. Serum ferritin level was estimated at baseline and then every 3 months. The initial dose of deferasirox was 20 mg/kg/body weight and was increased to 25 mg/kg if serum ferritin remained unchanged or increased 3 months after deferasirox therapy. RESULTS: Therapy with deferasirox in 40 children was well tolerated. Gastro-intestinal symptoms were the most common side-effects. Nausea, vomiting and abdominal pain were observed in 25%, 20% and 15% patients, respectively. Skin rashes were seen in 5% cases. We observed greyish-brown pigmentation of the skin in four (10%) children which has not been described before. A non-progressive rise in serum creatinine was observed in 16 (40%) patients. In the majority, however, serum creatinine remained within the normal range. Leucopenia, neutropenia and thrombocytopenia were not observed. None of the side-effects necessitated cessation of the drug therapy. Serum ferritin levels fell in 24 of 32 patients (75%) who received deferasirox for over 1 year from a mean (SD) 6323·37 (2756·5) μg/L to 5458·91 (2301·2) μg/L (p<0·05). CONCLUSIONS: Therapy with deferasirox is safe in paediatric patients with thalassaemia major. However, they should be carefully monitored for side-effects. |
| | |
Authors:
|
J Chandra; H Chaudhary; H Pemde; V Singh; A K Dutta |
Related Documents
:
|
17565429 - Evaluation of plantar hyperhidrosis in patients undergoing video-assisted thoracoscopic... 9071929 - Oesophageal manometry in the evaluation of megacolon with onset in adult life. 11768819 - The crura and crura-sphincter pressure dynamics in patients with isolated upright and i... 19491829 - Comparison of the degree of duodenogastroesophageal reflux and acid reflux between pati... 16995969 - Ice cold carbonated water: a therapy for persistent hyperawareness of pharyngeal mucus ... 15448429 - Severe gastroesophageal reflux disease and cow milk hypersensitivity in infants and chi... 21350019 - A retrospective analysis of the effect of patient-specific factors on voriconazole conc... 15122769 - Asialoglycoprotein receptor facilitates hemolysis in patients with alcoholic liver cirr... 20614249 - Breathing pattern characterization in chronic heart failure patients using the respirat... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Annals of tropical paediatrics Volume: 31 ISSN: 1465-3281 ISO Abbreviation: Ann Trop Paediatr Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-01-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8210625 Medline TA: Ann Trop Paediatr Country: England |
Other Details:
|
Languages: eng Pagination: 47-51 Citation Subset: IM |
Affiliation:
|
5, Lecturer Flats, Lady Hardinge Medical College Campus, Bangla Sahib Road, New Delhi-110001, India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prevalence of rheumatic heart disease among school-children in Aden, Yemen.
Next Document: The role of Helicobacter pylori infection in gastro-oesophageal reflux in Iranian children.